Last reviewed · How we verify
NCT05723939
Carnosine Supplementation and Cardiovascular Function
NA trial testing Carnosine supplementation in Carnosine in 100 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Josip Juraj Strossmayer University of Osijek |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 100 |
| Start date | 1 September 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Croatia |
Drugs / interventions tested
- Carnosine supplementation
- Controls
Conditions studied
- Carnosine — all drugs for Carnosine →
Sponsor
Josip Juraj Strossmayer University of Osijek
Who can join
Adults 18 to 39, any sex, with Carnosine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Carnosine is a dipeptide synthesized in the body from β-alanine and L-histidine. It was originally discovered in skeletal muscle where it is present in larger amounts than in other tissues, but it is also found in high concentrations in the brain, heart, and gastrointestinal tissues of humans. Although its physiological role has not been completely understood yet, carnosine is a non-enzymatic free-radical scavenger and a natural antioxidant and has anti-inflammatory and neuroprotective properties. The hypothesis of this research is that the consumption of carnosine supplements in the form of capsules, as well as chicken meat enriched with carnosine (functional food) has a beneficial effect on vascular reactivity measured in different vascular basins, and the lipid profile with a positive effect on the reduction of oxidative stress and inflammatory response in healthy sedentary people. subjects and active athletes measured in different vascular basins. The main goal of this study is to investigate the influence of carnosine supplement consumption (in the form of capsules and functional food) on vascular and endothelial function in a population of healthy young subjects and active athletes.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Carnosine-enriched functional food enhances micro- and macrovascular endothelium-independent vasodilation in competitive athletes-a randomized study.
Perić L, Drenjančević I, Jukić I, Boris A, et al · · 2025 · cited 1× · PMID 39983097 · DOI 10.1139/apnm-2024-0458 -
Carnosine-Enriched Chicken Meat Improves Microvascular Function and Anti-Inflammatory Phenotype in Patients with Chronic Coronary Syndrome.
Uršić D, Kolobarić N, Drenjančević I, Mihaljević Z, et al · · 2026 · PMID 41901102 · DOI 10.3390/nu18060928 -
Antioxidant Effects of Carnosine-Enriched Chicken Meat Consumption in Athletes: Modulation of SOD Activity and Superoxide Levels-A Randomized Control Trial.
Kolobarić N, Perić L, Mihaljević Z, Šušnjara P, et al · · 2025 · PMID 41008974 · DOI 10.3390/antiox14091069 -
Assessment of Micro- and Macronutrient Intake in Male Competitive Athletes Using the Epic-Norfolk Food Frequency Questionnaire.
Stupin A, Perić L, Jukić I, Boris A, et al · · 2025 · PMID 40141802 · DOI 10.3390/life15030458
Verify or expand the search:
- PubMed search for NCT05723939
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Josip Juraj Strossmayer University of Osijek trials
Trials by the same sponsor.
- NCT07437729 — Glycocalyx and Oxidative Stress in Endothelial Function (Part 1) · recruiting
- NCT07451873 — Glycocalyx and Oxidative Stress in Endothelial Function (Part 2) · recruiting
- NCT06545812 — Immune Response During the Conservative and Minimal Invasive Treatment of Pain Caused by Lumbar Disc Herniation · NA · completed
- NCT06316271 — Endothelial Function in Prehypertension · not yet recruiting
- NCT06316284 — miRNA in Chronic Kidney Diseases · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05723939 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Josip Juraj Strossmayer University of Osijek
- Last refreshed: 14 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05723939.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing